Basal insulin supported oral therapy in type 2 diabetes

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 5

Abstract

Early intensive glycemic control in type 2 diabetes reduces the risk of long-term complications, and often requires timely initiation and optimization of insulin therapy. While there are several patient and physician-related barriers to early insulin initiation, basal insulin supported oral antidiabetic therapy (BOT) offers an effective, more acceptable and safe way to transition to insulin therapy in type 2 diabetes. Basal insulin, when combined with oral antidiabetic medications with complementary mechanisms of action, targets multiple pathophysiological defects and results in better glycemic control. Another advantage is a reduced risk of side-effects such as hypoglycemia and weight gain, which are associated with more intensive insulin regimens. Basal insulin can be initiated once daily, at a dose of 0.1-0.2 units/kg and the dose can be further titrated based on fasting plasma glucose to achieve a target of 80-130 mg/dl. Oral therapy is individualized based on other factors such as baseline HbA1c, postprandial hyperglycemia, complications and comorbidities, socioeconomic considerations, lifestyle, patient preference and convenience. Further intensification of treatment may be required with addition of bolus insulin or GLP1 receptor agonist or switching to premixed insulin in individuals who are not able to maintain or sustain glycemic control on BOT regimen.

Authors and Affiliations

Gagan Priya

Keywords

Related Articles

Artificial sweeteners clinical perspective

Artificial sweeteners (AS) are substances with intense sweetening properties that can be added in small quantities to various foods to enhance its flavour without adding any extra calories. AS has always been under scrut...

Diaphyseal aclasis : study of imaging pattern and associated deformities

Hereditary multiple exostosis, also known as Diaphyseal aclasis is characterised by development of multiple exostosis. We report two cases of diaphyseal aclasis who presented to the outpatient orthopaedics department of...

Type 2 Diabetes reversal in India : Is a low carbohydrate diet practical and sustainable ?

The root cause of type 2 diabetes mellitus (T2DM) is carbohydrate intolerance and insulin resistance. From a scientific perspective, our body doesn’t need carbohydrates. While carbohydrate restriction per se can cut the...

Hypothryoidism : a treatable cause of erectile dysfunction

Sexual dysfunction is a common yet ignored part of medical consultation. Thyroid abnormalities is associated with sexual dysfunction most of which rectifies after normalising thyroid levels. This may reduce the need for...

Short term follow up study of proximal femoral nail antirotation (PFNA) in case of unstable peritrochanteric fractures

Comminuted Intertrochanteric fracture is a challenging problem in term of choice of implant for promoting osteosynthesis. These fracture presents with two challenges instability due to posteromedial and lateral comminut...

Download PDF file
  • EP ID EP612167
  • DOI -
  • Views 177
  • Downloads 0

How To Cite

Gagan Priya (2018). Basal insulin supported oral therapy in type 2 diabetes. Journal of the Indian Medical Association, 116(5), 22-25. https://europub.co.uk/articles/-A-612167